BRAIDWELL LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001920938

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2023 · 62 positions · Total reported value $2.13B · Top-10 concentration 41.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.0% · 24 new · 32 cut · 25 exited

Active Share (vs S&P 500): 98.9% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +24.0% · vs SPY +9.2% · Prev Value $2.64B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2023 13F filing, BRAIDWELL LP disclosed 62 equity positions with a combined reported value of $2.13B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 41.6% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were ASND ($130.39M), HSCS ($123.14M), NVCR ($117.92M). By sector, the heaviest allocations are Health Care 85.9%, Industrials 2.0%. Versus the prior quarter, allocation shifted toward Health Care (+4.7pp) and away from Industrials (-4.8pp).

Versus the prior quarter, BRAIDWELL LP opened 24 new positions, trimmed 32 and fully exited 25, a turnover rate of 75.0% of positions. The portfolio's overlap with the prior quarter was 68% of names.

The largest new positions opened in Q4 2023 were TNDM ($67.18M), ARGX ($58.28M), TRML ($23.74M).

Of the 25 positions fully exited versus the prior quarter, the largest were BSX ($61.50M), NTRA ($44.79M), ISRG ($33.59M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • TNDM TANDEM DIABETES · $67.18M
  • ARGX ARGENX SE · $58.28M
  • TRML TOURMALINE BIO INC · $23.74M
  • GPCR STRUCTURE THERAPEUTICS INC · $11.42M
  • SYRE SPYRE THERAPEUTICS INC · $11.08M
  • MRUS MERUS N V · $10.19M
  • DNLI DENALI THERAPEUTICS INC · $9.91M

Fully Exited (vs previous quarter)

  • BSX BOSTON SCIENTIFIC CORP · prev qtr: $61.50M · history
  • NTRA NATERA INC · prev qtr: $44.79M · history
  • ISRG INTUITIVE SURGICAL INC · prev qtr: $33.59M · history
  • BCYC BICYCLE THERAPEUTICS PLC · prev qtr: $25.91M
  • ETNB 89BIO INC · prev qtr: $24.56M
  • AXNX AXONICS INC · prev qtr: $19.90M
  • DHR DANAHER CORP DEL · prev qtr: $19.15M · history
  • ANAB ANAPTYSBIO INC COM · prev qtr: $18.85M

Insider Transactions (Form 4)

Latest BRAIDWELL LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Braidwell LP, based in Stamford, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 83 positions worth $2.54B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: STAMFORD, CT, United States
  • SEC registration: 801-122966 (status: Approved), registered 2022-01-03
  • Regulatory AUM (Form ADV): $3.63B as of 2026-09-22
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 12 private funds, of which 11 hedge funds
  • Website: braidwell.com

Portfolio Structure

  • 83 positions · $2.54B reported value (Q2 2026)
  • Top 10 holdings = 32.8% of reported value
  • Largest position: CAI (CARIS LIFE SCIENCES INC) at 5.8%
  • Average position size: $30.62M

Sector Tilt

  • Health Care 90.1%
  • Information Technology 4.3%
  • Industrials 4.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 24 new, 21 added, 32 reduced, 25 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 85.9%
Other 12.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 126.90M $130.39M 6.13%
6.13%
Add
2 131.00M $123.14M 5.79%
5.79%
Hold
3 135.83M $117.92M 5.55%
5.55%
Hold
4 715.21K $94.24M 4.43%
4.43%
Reduce
5 1.29M $81.01M 3.81%
3.81%
Reduce
6 1.65M $75.88M 3.57%
3.57%
Reduce
7 63.00M $72.70M 3.42%
3.42%
Add
8 71.05M $67.18M 3.16%
3.16%
New
9 4.22M $61.55M 2.90%
2.90%
Add
10 568.16K $60.82M 2.86%
2.86%
Hold
11 153.20K $58.28M 2.74%
2.74%
New
12 67.29M $57.33M 2.70%
2.70%
Hold
13 52.39M $56.12M 2.64%
2.64%
Add
14 222.79K $56.04M 2.64%
2.64%
Add
15 50.67M $51.52M 2.42%
2.42%
Add
16 45.00M $47.20M 2.22%
2.22%
Add
17 1.12M $44.49M 2.09%
2.09%
Reduce
18 3.36M $41.79M 1.97%
1.97%
Hold
19 611.37K $41.77M 1.97%
1.97%
Reduce
20 75.75K $40.21M 1.89%
1.89%
Hold
21 146.31K $40.09M 1.89%
1.89%
Add
22 1.78M $38.23M 1.80%
1.80%
Hold
23 184.66K $37.56M 1.77%
1.77%
Add
24 1.11M $36.01M 1.69%
1.69%
Add
25 5.72M $34.25M 1.61%
1.61%
Add
26 562.60K $33.85M 1.59%
1.59%
Reduce
27 5.04M $33.02M 1.55%
1.55%
Add
28 65.98M $32.99M 1.55%
1.55%
Hold
29 495.10K $30.70M 1.44%
1.44%
Add
30 3.32M $26.53M 1.25%
1.25%
Reduce
31 196.20K $24.34M 1.15%
1.15%
Add
32 906.82K $23.74M 1.12%
1.12%
New
33 758.93K $20.53M 0.97%
0.97%
Add
34 242.76K $19.30M 0.91%
0.91%
Reduce
35 681.10K $19.03M 0.90%
0.90%
Add
36 1.17M $18.86M 0.89%
0.89%
Reduce
37 102.70K $18.47M 0.87%
0.87%
Reduce
38 2.02M $17.41M 0.82%
0.82%
Hold
39 15.50M $16.87M 0.79%
0.79%
Add
40 1.50M $16.78M 0.79%
0.79%
Reduce
41 58.20K $16.76M 0.79%
0.79%
Add
42 2.32M $15.04M 0.71%
0.71%
Reduce
43 1.32M $14.44M 0.68%
0.68%
Reduce
44 2.40M $12.99M 0.61%
0.61%
Hold
45 1.24M $12.64M 0.59%
0.59%
Reduce
46 280.16K $11.42M 0.54%
0.54%
New
47 16.85M $11.12M 0.52%
0.52%
Reduce
48 515.00K $11.08M 0.52%
0.52%
New
49 370.68K $10.19M 0.48%
0.48%
New
50 755.81K $10.05M 0.47%
0.47%
Reduce

FAQ

What did BRAIDWELL LP buy in 2023-Q4?

In its 2023-Q4 13F filing, BRAIDWELL LP reported 62 equity positions worth $2.13B in aggregate; its largest disclosed positions were ASND ($130.39M), HSCS ($123.14M), NVCR ($117.92M).

How large is BRAIDWELL LP's portfolio?

BRAIDWELL LP reported $2.13B of long equity holdings across 62 positions as of 2023-Q4. Top-10 holdings account for 41.6% of reported value.

What is BRAIDWELL LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/braidwell/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →